Institut National de la Santé Et de la Recherche Médicale, France clinical trial pipeline

7 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 3 with minor changes only.

1. Notable

   Eurbio-Alport · (RaDiCo Cohort) (RaDiCo Eurbio-Alport)

   Primary and study completion pushed from Jun 30, 2026 to Sep 30, 2027

   Institut National de la Santé Et de la Recherche Médicale, France·Not specified· NCT05927467· Registry history of NCT05927467 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

2. Notable

   ICONIC · Multimodal Cardiovascular and Hepatic Population Imaging

   Primary endpoint(s) modified

   Institut National de la Santé Et de la Recherche Médicale, France·Not specified· NCT06906042· Registry history of NCT06906042 on ClinicalTrials.gov (opens the registry)

   Updated Sep 18, 2026

3. Notable

   EpiMicro · Multi-level Approach of Brain Activity Using…EpiMicro · Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients

   Enrollment increased: 50 → 80 participants

   Institut National de la Santé Et de la Recherche Médicale, France·Not applicable· NCT04653012· Registry history of NCT04653012 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

4. Notable

   REVIIH-BT · Visual Telerehabilitation Program on Visual…REVIIH-BT · Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young · Hemianopsia Consecutive to a Brain Tumour

   Primary and study completion moved earlier from Sep 2029 to Dec 2026

   Institut National de la Santé Et de la Recherche Médicale, France·Not applicable· NCT07558395· Registry history of NCT07558395 on ClinicalTrials.gov (opens the registry)

   Updated Sep 16, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.